Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCR for Evaluating Malaria Vaccines (FP9/MVA ME-TRAP)
NCT00121823Phase 2Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jun 2004
- Modality
- Viral Vector Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of FP9 ME-TRAP and MVA ME-TRAP in malaria (3 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Suitability and acceptability of study method. Started Jun 2004; status: completed.
02
Drugs
FP9 ME-TRAPMVA ME-TRAP
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00121823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00121823.